Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants.
about
Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13)Prescription Stimulants' Effects on Healthy Inhibitory Control, Working Memory, and Episodic Memory: A Meta-analysisIntroduction to behavioral addictionsA review of pharmacogenetic studies of substance-related disordersAmphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults.Assessment between Dopamine Receptor D2 (DRD2) Polymorphisms and Schizophrenia in Korean Population.The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.Nucleus accumbens responses differentiate execution and restraint in reward-directed behavior.Assessing personality traits by questionnaire: psychometric properties of the Greek version of the Zuckerman-Kuhlman personality questionnaire and correlations with psychopathology and hostilityAggression, DRD1 polymorphism, and lesion location in penetrating traumatic brain injury.Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.The contribution of maternal stress to preterm birth: issues and considerations.Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats.A cross-species genetic analysis identifies candidate genes for mouse anxiety and human bipolar disorderFetal programming of body composition, obesity, and metabolic function: the role of intrauterine stress and stress biology.DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experienceGenetic factors modulating the response to stimulant drugs in humans.Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.Dopamine Regulates Approach-Avoidance in Human Sensation-Seeking.Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humansDopaminergic foundations of schizotypy as measured by the German version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE)-a suitable endophenotype of schizophrenia.Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.Genetic distribution and association analysis of DRD2 gene polymorphisms with major depressive disorder in the Chinese Han population.How phenotype and developmental stage affect the genes we find: GABRA2 and impulsivityCandidate gene studies of a promising intermediate phenotype: failure to replicate.Dopamine modulates risk-taking as a function of baseline sensation-seeking trait.Impulsivity and apathy in Parkinson's disease.PTSD risk associated with a functional DRD2 polymorphism in heroin-dependent cases and controls is limited to amphetamine-dependent individuals.Genetic polymorphisms influence recovery from traumatic brain injury.Genetic polymorphisms and traumatic brain injury: the contribution of individual differences to recovery.Does response inhibition have pre- and postdiagnostic utility in Parkinson's disease?Contrasting roles for dopamine D1 and D2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats.Fuel not fun: Reinterpreting attenuated brain responses to reward in obesityIndividual differences in the reinforcing and subjective effects of d-amphetamine: Dimensions of impulsivity.Dopamine Gene Profiling to Predict Impulse Control and Effects of Dopamine Agonist Ropinirole.DRD2: Bridging the Genome and Ingestive Behavior.Gene polymorphisms associated with temperament.Constraints on decision making: implications from genetics, personality, and addiction.Prefrontal cortex executive processes affected by stress in health and disease.
P2860
Q21134099-267E119D-9CE0-4B0B-AE68-CC733147E192Q22241909-E2D00014-4A80-40F7-8FBE-70EC2E323A74Q24608377-275BB9CB-EFDB-40AD-B7D9-2EB5B97C818DQ27312296-C2747512-343A-4944-901C-052453728616Q30439296-AFDAB8E6-49BA-42AA-8A21-4B7FB8B9B3E3Q30458046-84CFE4CD-B868-42C9-B077-9066E15A7BCFQ30471555-B9F13697-0A83-4F84-8B29-1D6C93A8D4B9Q33440199-F4253136-7613-4E4C-8846-2783F8D58DEAQ33899292-20792FEE-AE5F-4809-96F4-C73FAA5708BFQ34167783-62BF7FE5-BBD4-4D6C-928E-E876605B31F1Q34233183-A8041E80-79C8-4E44-B54B-F37A3BD7E729Q35232097-052431BE-37BA-484D-B921-B2716A3559B2Q35644125-6600EEB9-3BCD-4318-830E-33B10E07570AQ35802831-B3A285E9-4624-4CCB-B19E-01F586303A3CQ35986523-EFABA6C9-30D9-45C2-A65B-C42F0D8699A8Q36054572-02ED0E28-F13D-4E7C-AA96-EF05942A8E19Q36071808-56762B31-BFD4-4B84-A769-D25A35D46F22Q36252863-CBB1052E-AC80-4954-87F8-A42BC7B4962BQ36287869-F5AFBB0D-EE8C-418C-BC49-D8338A08EFDDQ36354160-57C20F58-BDC8-4631-B7ED-5B124AA7A689Q36453185-46F7F3E0-DDB3-453B-B893-A9D5010FFD94Q36557505-4FAB50EA-3415-4928-AE33-5BCB491B3C9DQ36759490-74C12359-4957-461B-B817-46EB0993BC91Q36853446-A4F4B5D4-319B-496B-916B-0CB0C24FFEF9Q36873867-9FC70F10-6FE6-4D80-A9E3-493E9B22B39EQ36901154-87A1BE89-69D4-4730-9FF7-7EE11E352DEEQ37076311-CCBAB941-A6F1-4FDA-9733-81AFC2CF1926Q37331607-444C1DB6-0CB9-49BC-9477-C1F35B459C1DQ37445821-FCF600B4-BCD8-4EB3-83BC-F17C1A08E349Q37991924-3BABCD4B-5E09-459B-927A-044D05680559Q38033463-965B514D-68A6-4657-8195-B9092C486B8DQ38313013-8A99632D-4AF7-4188-A081-53837DE01DD3Q38443859-5A16AA4E-2254-4BAD-A415-35408033094CQ38546621-9268E720-1FAB-44F4-8A7A-C1C3FFB2B15BQ39120611-8EF78A1C-04E3-4D94-B2D8-B237C00E262CQ39136481-71BF61B0-7554-455E-9830-9F28E07C2396Q39217375-590BFD3F-B3EE-4A13-A7AF-DFB500FE660FQ39309327-3E95048F-AE5F-46B4-A83F-12201FE77CA6Q39422203-03BBBD2D-DCBB-4606-B877-BB039914FDFEQ39424256-912C45CE-5B82-4F7C-BC3E-694F368B240D
P2860
Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Evaluation of genetic variabil ...... amine in healthy participants.
@ast
Evaluation of genetic variabil ...... amine in healthy participants.
@en
type
label
Evaluation of genetic variabil ...... amine in healthy participants.
@ast
Evaluation of genetic variabil ...... amine in healthy participants.
@en
prefLabel
Evaluation of genetic variabil ...... amine in healthy participants.
@ast
Evaluation of genetic variabil ...... amine in healthy participants.
@en
P2093
P2860
P356
P1476
Evaluation of genetic variabil ...... amine in healthy participants.
@en
P2093
Abraham A Palmer
Ajna Hamidovic
Andrea Dlugos
Andrew Skol
P2860
P304
P356
10.1037/A0017840
P577
2009-12-01T00:00:00Z